NPI: 1528036050 · DAYTONA BEACH, FL 32114 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,543 | $4.47M |
| 2019 | 26,377 | $4.75M |
| 2020 | 28,506 | $3.22M |
| 2021 | 20,256 | $1.23M |
| 2022 | 13,399 | $1.20M |
| 2023 | 3,151 | $275K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 39,519 | 2,382 | $4.98M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,458 | 1,768 | $4.44M |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,979 | 1,220 | $2.26M |
| J1756 | Injection, iron sucrose, 1 mg | 6,994 | 1,565 | $813K |
| A4657 | Syringe, with or without needle, each | 3,279 | 2,025 | $732K |
| 85041 | 2,521 | 1,682 | $293K | |
| 85048 | 2,524 | 1,686 | $293K | |
| 82728 | 1,653 | 1,170 | $237K | |
| 83970 | 1,741 | 1,217 | $220K | |
| 83540 | 1,682 | 1,177 | $206K | |
| 83550 | 1,657 | 1,165 | $204K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 894 | 428 | $172K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,242 | 728 | $169K |
| 82108 | 574 | 404 | $65K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 163 | 109 | $17K |
| 82746 | 139 | 101 | $17K | |
| 82607 | 98 | 77 | $14K | |
| 90674 | 55 | 40 | $7K | |
| G0008 | Administration of influenza virus vaccine | 48 | 35 | $5K |
| 82947 | 12 | 12 | $494.01 |